PUResNetV2.0:一个深度学习模型,利用稀疏表示来改进连接体结合部位预测
Kandel Jeevan1, Shrestha Palistha2, Hilal Tayara3
1Graduate School of Integrated Energy-AI, Jeonbuk National University, Jeonju, 54896, South Korea.
Journal of cheminformatics
|June 7, 2024
概括
蛋白UNetResNetV2.0 (PUResNetV2.0) 通过稀疏的蛋白质结构增强了联体结合位点预测 (LBSP). 这种计算工具对药物发现有希望,尽管存在特定分子类型的局限性.
科学领域:
- 计算生物学是一种计算生物学.
- 结构生物信息学 结构生物信息学
- 药物发现 药物发现
背景情况:
- 准确的连接物结合部位预测 (LBSP) 对于识别潜在的候选药物至关重要.
- 现有的方法在预测各种蛋白质结构的结合点方面面临挑战.
研究的目的:
- 开发和评估ProteinUNetResNetV2.0 (PUResNetV2.0),这是一个新的方法,用于LBSP.
- 为了利用蛋白质结构的稀疏表示来提高预测准确性.
主要方法:
- 开发了PUResNetV2.0,这是一个包含稀疏表示的深度学习模型.
- 在来自4729个蛋白质家族的蛋白质复合物的数据集上训练模型.
- 在基准数据集上评估性能,包括Holo801.
主要成果:
- 在Holo801数据集上,PUResNetV2.0实现了85.4%的距离中心原子 (DCA) 成功率和74.7%的F1得分.
- 该方法的性能优于现有的LBSP技术.
- 由于训练数据的限制,对RNA,DNA,类似的配体和离子结合点的性能受到限制.
结论:
- 稀疏的表现显示了改善LBSP的巨大潜力,特别是对于寡合蛋白质结构.
- PUResNetV2.0代表了计算药物发现工具的一个有前途的进步.
- 需要进一步细化训练数据,以解决预测特定连接体类型的局限性.
相关概念视频
Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K


